BamSEC and AlphaSense Join Forces
Learn More

Gossamer Bio Inc. – Indentures

NASDAQ: GOSS    
Share price (10/15/26): $8.89    
Market cap (10/15/26): $54.4 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.3
from 8-K 14 pages Form of Warrant to Purchase Series A-3 Preferred Stock, Common Stock or Pre-Funded Warrants Gossamer Bio, Inc
12/34/56
EX-4.2
from 8-K 14 pages Form of Pre-Funded Warrant to Purchase Series A-2 Preferred Stock or Common Stock Gossamer Bio, Inc
12/34/56
EX-4.1
from 8-K 14 pages Form of Pre-Funded Warrant to Purchase Series A-1 Preferred Stock or Common Stock Gossamer Bio, Inc
12/34/56
EX-4.4
from S-3ASR 48 pages Gossamer Bio, Inc. Indenture Dated as of , 20___ [ ] Trustee
12/34/56
EX-4.1
from 8-K 17 pages Common Stock Purchase Warrant Gossamer Bio, Inc
12/34/56
EX-4.4
from S-3ASR 46 pages Gossamer Bio, Inc. Indenture Dated as of , 20___ [ ] Trustee
12/34/56
EX-4.3
from 10-K 4 pages Description of Gossamer Bio, Inc. Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.2
from 8-K 96 pages Gossamer Bio, Inc. and Wilmington Trust, National Association as Trustee First Supplemental Indenture Dated as of May 21, 2020 5.00% Convertible Senior Notes Due 2027 Cross Reference Table*
12/34/56
EX-4.1
from 8-K 52 pages Gossamer Bio, Inc. Indenture Dated as of May 21, 2020 Wilmington Trust, National Association, as Trustee
12/34/56
EX-4.4
from S-3ASR 51 pages Gossamer Bio, Inc. Indenture Dated as of , 20___ [ ] Trustee
12/34/56
EX-4.3
from 10-K 4 pages Description of Gossamer Bio, Inc. Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from S-1/A 2 pages Indenture or similar
12/34/56
EX-4.2
from S-1 102 pages Gossamer Bio, Inc. Amended and Restated Investors’ Rights Agreement July 20, 2018
12/34/56
EX-4.2
from DRS 102 pages Gossamer Bio, Inc. Amended and Restated Investors’ Rights Agreement July 20, 2018
12/34/56